Tumor Necrosis Factor Alpha News and Research

RSS
Analysis shows Remicade reduces pain associated with Crohn's disease

Analysis shows Remicade reduces pain associated with Crohn's disease

New anti-inflammatory strategy for cancer therapy

New anti-inflammatory strategy for cancer therapy

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

3 or 4 glasses of wine a week can kill cancer cells

3 or 4 glasses of wine a week can kill cancer cells

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

500,000 patients have now been treated with REMICADE® worldwide

500,000 patients have now been treated with REMICADE® worldwide

FDA accepts REMICADE® (infliximab) for the treatment of early rheumatoid arthritis

FDA accepts REMICADE® (infliximab) for the treatment of early rheumatoid arthritis